CVR: 37208035
Secondary names: A Pure Mind ApS
Previous names: TREATMENT ApS
DKK 410,337
Gross profit
Net result: DKK 101,980
Tove Resen Holding ApS, Power the Future ApS
1 more
CVR · view ownership and management
Director registered: Anne Simmenæs
CVR · 24/06/2026
View the full event history
TREATMENT PHARMA ApS is a Danish company of the type Anpartsselskab based in Horsens, founded in 2015. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named TREATMENT ApS. The management consists of Anne Simmenæs. The company is owned by Tove Resen Holding ApS, Power the Future ApS and Anne Simmenæs Holding ApS. The company has 1 employee (2016). In 2025, the company reported a gross profit of DKK 410,337 and a net result of DKK 101,980 compared with DKK -38,290 the year before. Equity in the 2025 report amounted to DKK 187,516.
Virksomhedens formål er drive virksomhed med fremstilling og videresalg af naturligt kosttilskud
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 410 t. | 102 t. | 512 t. | 188 t. | 1 | |
| 202401/01/2024 – 31/12/2024 | -37 t. | -38 t. | 376 t. | 86 t. | 0 | |
| 202301/01/2023 – 31/12/2023 | -45 t. | -47 t. | 70 t. | -76 t. | 1 | |
| 202201/01/2022 – 31/12/2022 | -23 t. | -24 t. | 222 t. | -29 t. | - | |
| 202101/01/2021 – 31/12/2021 | -3 t. | -3 t. | 2 t. | -5 t. | - | |
| 202001/01/2020 – 31/12/2020 | -3 t. | 163 t. | 2 t. | -3 t. | - | |
| 201901/01/2019 – 31/12/2019 | -3 t. | -5 t. | 1 t. | -165 t. | 1 | |
| 201801/01/2018 – 31/12/2018 | -7 t. | -53 t. | 3 t. | -160 t. | - | |
| 201701/01/2017 – 31/12/2017 | -10 t. | -12 t. | 46 t. | -107 t. | - |
Compared to 169 companies in Fremstilling af andre fødevarer i.a.n.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorTREATMENT PHARMA ApS was founded on 5 November 2015.
TREATMENT PHARMA ApS is registered under the industry Fremstilling af andre fødevarer i.a.n. (industry code 108900).
TREATMENT PHARMA ApS had 1 employee in 2016 according to the Danish CVR register.
TREATMENT PHARMA ApS is owned by Tove Resen Holding ApS, Power the Future ApS and Anne Simmenæs Holding ApS.
apuremind.dk belongs to TREATMENT PHARMA ApS, CVR number 37208035.
In 2025, TREATMENT PHARMA ApS reported a gross profit of DKK 410,337.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 31214282, new email: [email protected], new website: www.apuremind.dk (July 3, 2026).
TREATMENT PHARMA ApS has published its annual report for 2025. Gross profit came to DKK 410,337, and the net result was DKK 101,980.
As of June 24, 2026, Anne Simmenæs is registered as director of TREATMENT PHARMA ApS.
Contact info changed: new phone: 31214282, new email: [email protected], new website: www.apuremind.dk (May 1, 2026).
Contact info changed: new phone: 31214282, new email: [email protected], new website: www.apuremind.dk (April 30, 2026).
As of April 30, 2026, Anne Simmenæs has stepped down as director of TREATMENT PHARMA ApS.
Contact info changed: new phone: 31214282, new email: [email protected], new website: www.apuremind.dk (March 29, 2026).
As of October 3, 2025, Anne Simmenæs Holding ApS is registered as an owner of TREATMENT PHARMA ApS with an ownership share of 33%.
TREATMENT PHARMA ApS has published its annual report for 2024. Gross profit came to DKK -36,904, and the net result was DKK -38,290.
TREATMENT PHARMA ApS has published its annual report for 2023. Gross profit came to DKK -44,723, and the net result was DKK -47,171.
As of January 16, 2024, Anne Simmenæs is registered as director of TREATMENT PHARMA ApS.
As of January 16, 2024, Tove Resen has stepped down as director of TREATMENT PHARMA ApS.
As of January 15, 2024, Power the Future ApS is registered as an owner of TREATMENT PHARMA ApS with an ownership share of 25%.
TREATMENT PHARMA ApS has published its annual report for 2022. Gross profit came to DKK -22,856, and the net result was DKK -23,841.
On September 25, 2022, the company changed its name from TREATMENT ApS to TREATMENT PHARMA ApS.
TREATMENT PHARMA ApS has published its annual report for 2021. Gross profit came to DKK -3,351, and the net result was DKK -2,623.
TREATMENT PHARMA ApS has published its annual report for 2020. Gross profit came to DKK -3,351, and the net result was DKK 162,827.
TREATMENT PHARMA ApS has published its annual report for 2019. Gross profit came to DKK -3,443, and the net result was DKK -5,045.
TREATMENT PHARMA ApS has published its annual report for 2018. Gross profit came to DKK -6,740, and the net result was DKK -52,865.
TREATMENT PHARMA ApS has published its annual report for 2017. Gross profit came to DKK -9,536, and the net result was DKK -12,097.
TREATMENT PHARMA ApS has published its interim report for the period November 5, 2015 – December 31, 2016.
As of November 5, 2015, Tove Resen is registered as director of TREATMENT PHARMA ApS.
As of November 5, 2015, Tove Resen Holding ApS is registered as an owner of TREATMENT PHARMA ApS with an ownership share of 25%.
TREATMENT PHARMA ApS was founded on November 5, 2015.
Companies in the same industry and area
CVR 38593927
CVR 46761154
CVR 41452749
CVR 44146991
CVR 41766360
